TCW Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Buy |
27,625
+185
| +0.7% | +$14.5K | 0.02% | 252 |
|
|
2025
Q1 | $1.99M | Buy |
27,440
+4,575
| +20% | +$332K | 0.02% | 253 |
|
|
2024
Q4 | $1.69M | Buy |
+22,865
| New | +$1.69M | 0.01% | 270 |
|
|
2021
Q2 | – | Sell |
-13,962
| Closed | -$1.17M | – | 343 |
|
|
2021
Q1 | $1.17M | Hold |
13,962
| – | – | 0.01% | 282 |
|
|
2020
Q4 | $1.27M | Sell |
13,962
-2,495
| -15% | -$228K | 0.01% | 275 |
|
|
2020
Q3 | $1.31M | Buy |
16,457
+41
| +0.2% | +$3.27K | 0.01% | 253 |
|
|
2020
Q2 | $1.14M | Buy |
+16,416
| New | +$1.14M | 0.01% | 237 |
|
|
2017
Q1 | – | Sell |
-47,250
| Closed | -$1.48M | – | 462 |
|
|
2016
Q4 | $1.48M | Hold |
47,250
| – | – | 0.01% | 418 |
|
|
2016
Q3 | $1.9M | Sell |
47,250
-3,900
| -8% | -$157K | 0.01% | 341 |
|
|
2016
Q2 | $1.7M | Buy |
51,150
+1,200
| +2% | +$39.9K | 0.01% | 364 |
|
|
2016
Q1 | $1.47M | Buy |
49,950
+150
| +0.3% | +$4.41K | 0.01% | 406 |
|
|
2015
Q4 | $1.31M | Buy |
+49,800
| New | +$1.31M | 0.01% | 442 |
|
|
2015
Q2 | – | Sell |
-188,100
| Closed | -$4.47M | – | 678 |
|
|
2015
Q1 | $4.47M | Buy |
188,100
+8,100
| +5% | +$192K | 0.02% | 406 |
|
|
2014
Q4 | $3.82M | Sell |
180,000
-131,700
| -42% | -$2.8M | 0.02% | 469 |
|
|
2014
Q3 | $5.31M | Sell |
311,700
-5,400
| -2% | -$91.9K | 0.02% | 463 |
|
|
2014
Q2 | $4.54M | Sell |
317,100
-2,700
| -0.8% | -$38.6K | 0.02% | 522 |
|
|
2014
Q1 | $3.95M | Sell |
319,800
-5,100
| -2% | -$63K | 0.02% | 548 |
|
|
2013
Q4 | $3.56M | Sell |
324,900
-7,500
| -2% | -$82.2K | 0.02% | 578 |
|
|
2013
Q3 | $3.86M | Sell |
332,400
-660
| -0.2% | -$7.66K | 0.02% | 556 |
|
|
2013
Q2 | $3.73M | Buy |
+333,060
| New | +$3.73M | 0.02% | 525 |
|